Ozempic (semaglutide) takes effect in three distinct phases: appetite suppression first (within days), then measurable weight loss (weeks 4 to 8), then full therapeutic effect (months 3 to 6 as you reach the maintenance dose). Each phase has a typical timeline based on clinical trial data and population reports from prescribers.
This guide walks through what to expect at each phase, what factors change your individual timeline, and how meal delivery and protein intake affect how fast Ozempic works for you.
Within the first week of starting Ozempic at 0.25 mg, most users notice reduced appetite, smaller hunger signals between meals, and earlier fullness during meals. Some report decreased food cravings within 3 to 5 days. The semaglutide half life is about 7 days so steady state takes about 4 to 5 weeks, but acute appetite effects appear much sooner. The 0.25 mg starting dose is a tolerance ramp rather than a therapeutic dose, so weight loss in this phase is usually small (1 to 3 pounds).
Significant weight loss begins after dose escalation to 0.5 mg at week 5 and 1.0 mg at week 9. By week 8 most users have lost 3 to 7 percent of starting body weight in clinical trials. The rate of loss is fastest in the first 3 months and slows as you approach maintenance. Side effects (nausea, fatigue) tend to peak in this window because the dose is climbing.
Full therapeutic effect is reached at the maintenance dose, typically 1.0 to 2.0 mg weekly depending on tolerance and response. By month 6, the average semaglutide patient in the SUSTAIN clinical trials lost 5 to 10 percent of body weight on Ozempic. By month 12 the cumulative loss reaches 10 to 15 percent. Plateaus are common after month 6, often resolved by dose adjustment or behavior reinforcement.
| Week | Dose | Typical effect |
|---|---|---|
| Weeks 1 to 4 | 0.25 mg weekly | Tolerance ramp. Appetite drops, mild nausea common, weight loss 1 to 3 pounds. |
| Weeks 5 to 8 | 0.5 mg weekly | Therapeutic dose begins. Weight loss accelerates to 1 to 2 pounds per week for many users. |
| Weeks 9 to 12 | 1.0 mg weekly (or hold at 0.5) | Standard maintenance for Type 2 diabetes. Continued steady weight loss. |
| Weeks 13+ | 1.0 to 2.0 mg weekly | Full therapeutic effect. Most users plateau in months 6 to 9 and continue losing slowly. |
The biggest practical problem on Ozempic is that appetite drops fast but you still need adequate protein to preserve lean muscle. Meal delivery solves the planning and shopping load when appetite is unpredictable. The services below all publish per meal protein and have menu options optimized for GLP 1 eating patterns.
Full ranking at our GLP 1 meal delivery hub.
Most users notice reduced appetite within the first week of starting Ozempic at 0.25 mg. Measurable weight loss begins by week 4 to 8 as you escalate to 0.5 and 1.0 mg.
Average loss is 1 to 2 pounds per week during dose escalation (weeks 5 to 12). By 6 months, most users have lost 5 to 10 percent of starting body weight. By 12 months, 10 to 15 percent.
Common reasons: still in the 0.25 mg tolerance ramp (give it 4 to 8 weeks), not eating enough protein, plateau around month 6 to 9 (often resolved by dose increase), insufficient sleep or high stress. Talk with your prescriber if you have not seen any change by week 12.
Appetite suppression peaks 24 to 72 hours after each weekly injection and remains strong throughout the week at maintenance dose. The semaglutide half life is about 7 days.
Most users plateau at month 6 to 9 on maintenance dose. Plateaus are usually resolved by a dose adjustment, increased protein, more sleep, or strength training. Plateaus do not mean Ozempic stopped working.
Most clinical data shows weight loss continues for 12 to 18 months then stabilizes at the new maintenance weight. Stopping Ozempic typically leads to partial regain. Continuing food and exercise habits built during treatment makes a meaningful difference.
Answer 5 quick questions. We'll match you to the top 3 from 24 services we track.